Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 26, Issue 26, Pages 3059-3068Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612826666200116145559
Keywords
Computational drug repositioning; drug-disease association; indication; biological network; machine learning; sparse matrix; text mining
Categories
Funding
- National Natural Science Foundation of China [61972422, 61672541]
Ask authors/readers for more resources
Computational drug repositioning is an efficient approach towards discovering new indications for existing drugs. In recent years, with the accumulation of online health-related information and the extensive use of biomedical databases, computational drug repositioning approaches have achieved significant progress in drug discovery. In this review, we summarize recent advancements in drug repositioning. Firstly, we explicitly demonstrated the available data source information which is conducive to identifying novel indications. Furthermore, we provide a summary of the commonly used computing approaches. For each method, we briefly described techniques, case studies, and evaluation criteria. Finally, we discuss the limitations of the existing computing approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available